Inez Koopman

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Safety and pharmacodynamic efficacy of eculizumab in aneurysmal subarachnoid hemorrhage (CLASH): A phase 2a randomized clinical trial.

Safety and pharmacodynamic efficacy of eculizumab in aneurysmal subarachnoid hemorrhage (CLASH): A phase 2a randomized clinical trial.

Journal: European stroke journal

Published: August 22, 2023

Glial cell response and microthrombosis in aneurysmal subarachnoid hemorrhage patients: An autopsy study.

Glial cell response and microthrombosis in aneurysmal subarachnoid hemorrhage patients: An autopsy study.

Journal: Journal of neuropathology and experimental neurology

Published: July 21, 2023

Devastating delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.

Devastating delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.

Journal: Frontiers in neurology

Published: August 10, 2022

Rebleeding After Aneurysmal Subarachnoid Hemorrhage in Two Centers Using Different Blood Pressure Management Strategies.

Rebleeding After Aneurysmal Subarachnoid Hemorrhage in Two Centers Using Different Blood Pressure Management Strategies.

Journal: Frontiers in neurology

Published: December 15, 2021

Deferred Consent in an Acute Stroke Trial from a Patient, Proxy, and Physician Perspective: A Cross-Sectional Survey.

Deferred Consent in an Acute Stroke Trial from a Patient, Proxy, and Physician Perspective: A Cross-Sectional Survey.

Journal: Neurocritical care

Published: April 08, 2021

CompLement C5 Antibodies for decreasing brain injury after aneurysmal Subarachnoid Haemorrhage (CLASH): study protocol for a randomised controlled phase II clinical trial.

CompLement C5 Antibodies for decreasing brain injury after aneurysmal Subarachnoid Haemorrhage (CLASH): study protocol for a randomised controlled phase II clinical trial.

Journal: Trials

Published: June 10, 2020

The course of cerebrospinal fluid parameters ≤ 20 days after aneurysmal subarachnoid hemorrhage.

The course of cerebrospinal fluid parameters ≤ 20 days after aneurysmal subarachnoid hemorrhage.

Journal: Journal of the neurological sciences

Published: November 22, 2019

Aneurysm characteristics and risk of rebleeding after subarachnoid haemorrhage.

Aneurysm characteristics and risk of rebleeding after subarachnoid haemorrhage.

Journal: European stroke journal

Published: June 12, 2018

Early skin-to-skin contact for healthy full-term infants after vaginal and caesarean delivery: a qualitative study on clinician perspectives.

Early skin-to-skin contact for healthy full-term infants after vaginal and caesarean delivery: a qualitative study on clinician perspectives.

Journal: Journal of clinical nursing

Published: January 09, 2016

Showing 1-9 of 9

Last Updated: 09/26/2026